Rahul Parikh, M.D.

Education:

• B.S.                   Rensselaer Polytechnic Institute, Troy , NY                
• M.D.                   Albany Medical College , Albany , NY
• Residency          Robert Wood Johnson Medical School - UMDNJ

Academic Appointments:

• Resident Physician

Honors/Certificates:

• ASTRO Travel Grant to 50 th Annual Meeting, Boston , MA . September 2008
• ASTRO Travel Grant to Translational Research in Radiation Oncology, Physics, and Biology Symposium, September 2006
• Research Accomplishment Award – RPI/AMC Physician - Scientist Program, September 2003
• Awarded “The Dean's Certificate for Outstanding Research Endeavors” at Albany Medical College – May 2003
• Awards earned at Eastern Student Research Forum (ESRF), Miami , FL. February 2003:

  “Outstanding Molecular Medicine Presentation”

  “Outstanding Basic Science Oral Presentation – 1 st place”

  “Best Overall Basic Science Presentation”

  Awarded trip to represent AMC & ESRF at National Student Research Forum (NSRF), University of Texas – Medical Branch in Galveston , TX . April 2003

Selected Peer-Reviewed Publications for the Recent 5 Years

1. R. R. Parikh, D. Housman, Q. Yang, L. D. Wilson, B. G. Haffty. Prognostic Value of Triple-Negative Phenotype at the Time of Locally Recurrent, Conservatively-treated Breast Cancer. UMDNJ – Dept. of Radiation Oncology, Memorial Sloan-Kettering Cancer Center , Yale University – Dept. of Therapeutic Radiology. Int J of Radiat Oncol Biol Phys. 2008 Aug 1; [Epub ahead of print].
2. R. R. Parikh, Q. Yang, S. A. Higgins, B. G. Haffty. Outcomes In Young Women with Breast Cancer Of Triple-Negative Phenotype: The Prognostic Significance of CK19 Expression. Int J of Radiat Oncol Biol Phys. 2007 Sept 11; [Epub ahead of print].
3. Parikh R. R., Yang Q., Haffty B. G. Prognostic Significance of Vascular Endothelial Growth Factor protein levels in T1-2 N0 Laryngeal Cancer treated with Primary Radiation Therapy. Cancer. 2007 Feb 1;109(3):566-73.
4. Parikh R. R., Gildener-Leapman N, Narendran A, Lin HY, Lemanski N, Bennett JA, Jacobson HI, Andersen TT, Prevention of N-Methyl-N-Nitrosourea-Induced Breast Cancer by a-Fetoprotein (AFP)-Derived Peptide, a Peptide Derived from the Active Site of AFP. Clinical Cancer Research, 2005 Dec 1; 11(23): 8512-20.

Presentations at Scientific Meetings:

1. Poster Discussion Presentation. Ductal Carcinoma in Situ with Microinvasion: Prognostic Implications, Long-term Outcomes, and Role of Axillary Evaluation. ASTRO – 50 th Annual Meeting. Boston , MA . September 2008.
2. Poster Presentation. Prognostic Value of Triple-Negative Phenotype at the Time of Locally Recurrent, Conservatively-treated Breast Cancer . ASCO – Breast Cancer Symposium. San Francisco , CA . September 2007.
3. Oral Presentation. Outcomes In Young Women with Breast Cancer of Triple-negative (TN) Phenotype: The Prognostic Significance of CK19 Expression. ASTRO – 48 th Annual Meeting. Philadelphia , PA. November 2006.
4. Poster Presentation. Prognostic Significance of Vascular Endothelial Growth Factor protein levels in T1-2 N0 Laryngeal Cancer treated with Primary Radiation Therapy. ASTRO – Translational Research in Radiation Oncology, Physics, and Biology Symposium. Boston , MA . September 2006.
5. Poster Presentation. Prevention & Treatment of MNU-induced Breast Cancer by Alpha-fetoprotein – derived Peptide in a Preclinical Model. 25 th Annual AMS Medical Student Research Awards Program, Albany Medical College . Albany , NY . April 2006.
6. Oral Presentation. Prevention of MNU-induced ER+ Breast Cancer by AFPep: Duration of Drug Administration. Eastern Student Research Forum (ESRF), University of Miami . Miami , FL. February 2004.
7. Poster Presentation. A Peptide Derived from the Active Site of Alpha-Fetoprotein Prevents Breast Cancer in a Rat Model. American Association of Cancer Research (AACR) – 94th Annual Meeting. Washington , DC . July 2003.
8. Oral Presentation. Prevention of Breast Cancer by Alpha-fetoprotein – derived Peptide. National Student Research Forum (NSRF), University of Texas – Medical Branch. Galveston , TX . April 2003.
9. Poster Presentation. Prevention of MNU-induced ER+ Breast Cancer by Alpha-fetoprotein – derived Peptide. Medical Student Investigation Day at Albany Medical College . Albany , NY . 2003.
10. Oral Presentation. Prevention of Breast Cancer by Alpha-fetoprotein – derived Peptide. Eastern Student Research Forum (ESRF), University of Miami . Miami , FL. February 2003.